Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

临床使用C1抑制剂的安全性

C Erik Hack, Chris de Zwaan, Wim T Hermens

    Circulation
    |October 31, 2002
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

    mAbs·2026
    Same author

    Development of an anti-rat complement C2 antibody that improves renal outcome in a rat kidney transplant model.

    Frontiers in immunology·2026
    Same author

    IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

    Neurology(R) neuroimmunology & neuroinflammation·2025
    Same author

    Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.

    Nature communications·2025
    Same author

    Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2.

    European journal of neurology·2024
    Same author

    IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset.

    Journal of neuroinflammation·2024